Trends in pioglitazone use among U.S. adults with type 2 diabetes and suspected nonalcoholic fatty liver disease. uri icon

authors

  • Le, Phuc
  • Alexander Chaitoff, MD, MPH
  • Rothberg, Michael B
  • McCullough, Arthur
  • Alkhouri, Naim

publication date

  • December 24, 2019